title: Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
abstract: Accumulating evidences indicated that lncRNAs play crucial regulatory roles in oncogenesis and progression of cancers. BRAF activated non-coding RNA (BANCR) has been identified to contribute to the progression of some human cancers. However, the relationship between BANCR and bladder cancer (BC) is largely unclear.
  
  
  
  BANCR expression levels in BC, paired non-cancer tissues and BC cell lines were detected by real-time quantitative RT-PCR (qRT-PCR). The relationships between BANCR expression levels and the clinical characteristics were evaluated. BANCR expression was enhanced by transfecting a pcDNA-BANCR vector. We used both CCK-8 assay and Edu assay to detect cell proliferation. We also detect cell apoptosis and migration by using ELISA assay, Flow cytometry and transwell assay, respectively. All statistical analyses were executed by using the SPSS 20.0 software.
  
  
  
  BANCR expression levels were remarkably decreased in BC tissues compared with adjacent noncancerous tissues. BANCR expression levels in two BC cell lines were also significantly down-regulated. Clinicopathologic analysis revealed that low BANCR expression was positively correlated with TNM stage, but not associated with other clinicopathological characteristics. BANCR has been successfully overexpressed in BC cell lines (T24 and SW780) by transfecting a pcDNA-BANCR vector. Cell proliferation inhibition, apoptosis induction and migration suppression were also observed in pCDNA-BANCR-transfected T24 and SW780 cells.
  
  
  
  These data suggested that BANCR represents a tumor suppressor player in bladder cancer, contributes to tumor proliferation, apoptosis and migration, and may serve as a new candidate biomarker and a potential therapeutic target for patients with BC.
authors: Shenzhen Second People's Hospital, Clinical Medicine College of Anhui Medical University, Shenzhen, 518039, Guangdong, China.|Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.
authors: Anbang
authors: A
authors: He
authors: Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.
authors: Yuchen
authors: Y
authors: Liu
authors: Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.|Shantou University Medical College, Shantou, 515041, China.
authors: Zhicong
authors: Z
authors: Chen
authors: Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.|Shantou University Medical College, Shantou, 515041, China.
authors: Jianfa
authors: J
authors: Li
authors: Shenzhen Second People's Hospital, Clinical Medicine College of Anhui Medical University, Shenzhen, 518039, Guangdong, China.|Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.
authors: Mingwei
authors: M
authors: Chen
authors: Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.|Shantou University Medical College, Shantou, 515041, China.
authors: Li
authors: L
authors: Liu
authors: Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.
authors: Xinhui
authors: X
authors: Liao
authors: Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.
authors: Zhaojie
authors: Z
authors: Lv
authors: Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.|Shantou University Medical College, Shantou, 515041, China.
authors: Yonghao
authors: Y
authors: Zhan
authors: Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.|Shantou University Medical College, Shantou, 515041, China.
authors: Chengle
authors: C
authors: Zhuang
authors: Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.|Shantou University Medical College, Shantou, 515041, China.
authors: Junhao
authors: J
authors: Lin
authors: Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China. pony8980@163.com.
authors: Weiren
authors: W
authors: Huang
authors: Shenzhen Second People's Hospital, Clinical Medicine College of Anhui Medical University, Shenzhen, 518039, Guangdong, China. hbmei68@163.com.|Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China. hbmei68@163.com.
authors: Hongbing
authors: H
authors: Mei
mesh_terms: D017209:Apoptosis; D002295:Carcinoma, Transitional Cell / Q000235:genetics / Q000473:pathology*; D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D015536:Down-Regulation; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D062085:RNA, Long Noncoding / Q000235:genetics*; D001749:Urinary Bladder Neoplasms / Q000235:genetics / Q000473:pathology*
chemical_list: C000605290:BANCR long non-coding RNA, human; D062085:RNA, Long Noncoding
keywords: BANCR; Bladder cancer; LncRNAs; Therapeutic target